| Literature DB >> 12617912 |
Anders Bråthe1, Lise-Lotte Gundersen, Jon Nissen-Meyer, Frode Rise, Bjørn Spilsberg.
Abstract
6-Alkynyl- and 6-alkenylpurines have been screened for cytotoxic activity against a human chronic myelogenous leukemia cell line; K-562 cells using a [(3)H]-thymidine incorporation assay. Most alkynes displayed cytotoxicity comparable to, or better than, the known anticancer drugs 6-mercaptopurine and fludarabine. The 6-alkenylpurines, which are promising plant growth stimulators and 15-lipoxygenase inhibitors, exhibited only low toxicity.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12617912 DOI: 10.1016/s0960-894x(03)00011-8
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823